Literature DB >> 23178516

In vitro non-enzymatic ribation reduces post-yield strain accommodation in cortical bone.

Thomas L Willett1, Sibi Sutty, Anne Gaspar, Nick Avery, Marc Grynpas.   

Abstract

Non-enzymatic glycation (NEG) and advanced glycation endproducts (AGEs) may contribute to bone fragility in various diseases, ageing, and other conditions by modifying bone collagen and causing degraded mechanical properties. In this study, we sought to further understand how collagen modification in an in vitro non-enzymatic ribation model leads to loss of cortical bone toughness. Previous in vitro studies using non-enzymatic ribation reported loss of ductility in the cortical bone. Increased crosslinking is most commonly blamed for these changes; however, some studies report positive correlations between measures of total collagen crosslinking and work-to-fracture/toughness measurements whilst correlations between general NEG and measures of ductility are often negative. Fifteen bone beam triplets were cut from bovine metatarsi. Each provided one native non-incubated control, one incubated control and one ribated specimen. Incubation involved simulated body fluid±ribose for fourteen days at 37°C. Pentosidine and pyridinoline crosslinks were measured using HPLC. Three-point bending tests quantified mechanical properties. Fracture surfaces were examined using scanning electron microscopy. The effects of ribation on bone collagen molecular stability and intermolecular connectivity were investigated using differential scanning calorimetry and hydrothermal isometric tension testing. Ribation caused increased non-enzymatic collagen modification and pentosidine content (16mmol/mol collagen) and inferior post-yield mechanical behaviour, especially post-yield strain and flexural toughness. Fracture surfaces were smoother with less collagen fibril deformation or tearing than observed in controls. In the ribated group only, pentosidine content and thermomechanical measures of crosslinking were positively correlated with measures of strain accommodation and energy absorption before failure. Non-enzymatic ribation and the resulting modifications reduce cortical bone pseudo-plasticity through a reduced capacity for post-yield strain accommodation. However, the positive correlations we have found suggest that increased crosslinking may not provide a complete explanation for this embrittlement.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178516     DOI: 10.1016/j.bone.2012.11.014

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  12 in total

1.  Material heterogeneity in cancellous bone promotes deformation recovery after mechanical failure.

Authors:  Ashley M Torres; Jonathan B Matheny; Tony M Keaveny; David Taylor; Clare M Rimnac; Christopher J Hernandez
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

2.  Advanced glycation end-product cross-linking inhibits biomechanical plasticity and characteristic failure morphology of native tendon.

Authors:  J Michael Lee; Samuel P Veres
Journal:  J Appl Physiol (1985)       Date:  2019-01-17

Review 3.  The Role of Matrix Composition in the Mechanical Behavior of Bone.

Authors:  Mustafa Unal; Amy Creecy; Jeffry S Nyman
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

4.  In Vitro-Induced High Sugar Environments Deteriorate Human Cortical Bone Elastic Modulus and Fracture Toughness.

Authors:  Kelly Merlo; Jacob Aaronson; Rachana Vaidya; Taraneh Rezaee; Vijaya Chalivendra; Lamya Karim
Journal:  J Orthop Res       Date:  2019-12-08       Impact factor: 3.494

Review 5.  Effects of Diabetes on Bone Material Properties.

Authors:  Sashank Lekkala; Erik A Taylor; Heather B Hunt; Eve Donnelly
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

Review 6.  Collagen modifications in postmenopausal osteoporosis: advanced glycation endproducts may affect bone volume, structure and quality.

Authors:  Thomas L Willett; Julia Pasquale; Marc D Grynpas
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 7.  The impact of advanced glycation end products on bone properties in chronic kidney disease.

Authors:  John G Damrath; Amy Creecy; Joseph M Wallace; Sharon M Moe
Journal:  Curr Opin Nephrol Hypertens       Date:  2021-07-01       Impact factor: 3.416

8.  Assessing glycation-mediated changes in human cortical bone with Raman spectroscopy.

Authors:  Mustafa Unal; Sasidhar Uppuganti; Calen J Leverant; Amy Creecy; Mathilde Granke; Paul Voziyan; Jeffry S Nyman
Journal:  J Biophotonics       Date:  2018-05-06       Impact factor: 3.390

9.  Mass spectrometric quantitation of AGEs and enzymatic crosslinks in human cancellous bone.

Authors:  Shoutaro Arakawa; Ryusuke Suzuki; Daisaburo Kurosaka; Ryo Ikeda; Hiroteru Hayashi; Tomohiro Kayama; Rei-Ichi Ohno; Ryoji Nagai; Keishi Marumo; Mitsuru Saito
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

10.  N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder.

Authors:  Matthew R Allen; Joseph Wallace; Erin McNerney; Jeffry Nyman; Keith Avin; Neal Chen; Sharon Moe
Journal:  PLoS One       Date:  2020-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.